Journal article
Activation of the erythroid K-Cl cotransporter Kcc1 enhances sickle cell disease pathology in a humanized mouse model
FC Brown, AJ Conway, L Cerruti, JE Collinge, C McLean, JS Wiley, BT Kile, SM Jane, DJ Curtis
Blood | Published : 2015
Abstract
We used an N-ethyl-N-nitrosurea-based forward genetic screen in mice to identify new genes and alleles that regulate erythropoiesis. Here, we describe a mouse line expressing an activated form of the K-Cl cotransporter Slc12a4 (Kcc1), which results in a semidominant microcytosis of red cells. A missense mutation from methionine to lysine in the cytoplasmic tail of Kcc1 impairs phosphorylation of adjacent threonines required for inhibiting cotransporter activity. We bred Kcc1M935K mutant mice with a humanized mouse model of sickle cell disease to directly explore the relevance of the reported increase in KCC activity in disease pathogenesis. We show that a single mutant allele of Kcc1 induces..
View full abstractGrants
Awarded by Australian National Health and Medical Research Council
Funding Acknowledgements
This study was supported by a project grant (382900) from the Australian National Health and Medical Research Council (to S.M.J. and D.J.C.) and a Viertel Senior Medical Research fellowship (to D.J.C.).